• LAST PRICE
    12.3700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 12.3700
  • Day Range
    ---
  • 52 Week Range
    Low 8.9900
    High 30.4000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 12.35
TimeVolumePMVP
09:32 ET412812.22
09:34 ET80012.31
09:41 ET59112.35
09:45 ET20012.44
09:48 ET30012.36
09:50 ET50012.32
09:52 ET10012.32
10:01 ET20012.335
10:03 ET136412.27
10:06 ET21012.255
10:10 ET183312.27
10:14 ET39612.29
10:15 ET64412.29
10:17 ET40012.34
10:19 ET176612.275
10:21 ET30012.26
10:26 ET100012.235
10:28 ET80012.15
10:30 ET20012.13
10:33 ET10012.05
10:35 ET19012.05
10:39 ET175012.12
10:46 ET54012.167
10:48 ET10012.17
10:50 ET20012.18
10:53 ET140012.19
10:57 ET81212.21
11:00 ET76412.21
11:02 ET40012.2
11:06 ET60312.19
11:08 ET30012.2
11:09 ET168412.2
11:11 ET20012.2
11:18 ET90012.2
11:20 ET30012.28
11:22 ET105512.31
11:27 ET110012.26
11:31 ET50012.27
11:36 ET40012.28
11:38 ET188812.37
11:42 ET10012.38
11:45 ET59512.4
11:47 ET120712.43
11:49 ET10012.45
11:54 ET40012.47
11:58 ET120012.43
12:02 ET30012.36
12:12 ET10012.341
12:14 ET80012.38
12:18 ET20012.38
12:20 ET110012.37
12:21 ET10012.35
12:23 ET30012.36
12:25 ET20012.41
12:34 ET100012.38
12:36 ET40012.41
12:45 ET38012.43
12:48 ET92212.421
12:52 ET60012.42
12:57 ET50012.42
01:01 ET100012.391
01:08 ET35312.42
01:10 ET60012.36
01:14 ET50112.41
01:15 ET30012.4
01:19 ET60012.36
01:28 ET30012.35
01:33 ET70012.3
01:39 ET130012.33
01:44 ET40112.32
01:46 ET10012.33
01:51 ET100412.38
01:53 ET10012.4
01:55 ET35412.42
02:04 ET120012.41
02:06 ET161112.39
02:13 ET190012.44
02:15 ET10012.43
02:18 ET70012.41
02:20 ET10012.4
02:22 ET60012.41
02:24 ET10012.42
02:27 ET33812.42
02:29 ET110012.41
02:31 ET20012.41
02:33 ET10012.415
02:36 ET79912.41
02:38 ET20012.42
02:40 ET471412.39
02:45 ET60012.36
02:51 ET30012.33
02:56 ET130012.32
03:00 ET90012.36
03:02 ET40012.34
03:03 ET50012.33
03:07 ET80412.37
03:09 ET10012.38
03:12 ET20012.365
03:14 ET60012.38
03:16 ET70012.425
03:18 ET120112.44
03:20 ET69312.46
03:21 ET80112.47
03:23 ET108712.49
03:25 ET140012.48
03:27 ET10012.48
03:30 ET64012.485
03:32 ET30012.49
03:34 ET72512.5
03:36 ET10012.51
03:38 ET160412.535
03:39 ET73312.54
03:41 ET135412.54
03:43 ET50012.55
03:45 ET60012.56
03:48 ET210012.56
03:50 ET30012.54
03:52 ET1076112.5
03:54 ET306312.44
03:56 ET1066012.42
03:57 ET1015812.38
03:59 ET15575112.37
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPMVP
PMV Pharmaceuticals Inc
542.9M
-8.1x
---
United StatesAURA
Aura Biosciences Inc
530.4M
-7.8x
---
United StatesKNTE
Kinnate Biopharma Inc
527.0M
-4.9x
---
United StatesALLK
Allakos Inc
518.5M
-0.9x
---
United StatesHLVX
Hillevax Inc
571.3M
0.0x
---
United StatesJANX
Janux Therapeutics Inc
564.1M
-10.2x
---
As of 2022-10-07

Company Information

PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The Company’s lead product candidate, PC14586, is an orally available small molecule designed to potently and selectively correct p53 misfolding caused by a specific p53 mutation, Y220C, while sparing wild type p53. PC14586 is designed to restore the wild-type conformation by occupying the crevice created by the tyrosine to cysteine mutation in amino acid position 220. The Company is also using its precision oncology platform to develop a pipeline of oral small molecule product candidates, which structurally correct other p53 hotspot mutations to restore their wild-type function and product candidates that target certain cancers where wild-type p53 function is silenced.

Contact Information

Headquarters
8 Clarke DriveCRANBURY, NJ, United States 08512
Phone
609-642-6664
Fax
302-655-5049

Executives

Independent Chairman of the Board
Richard Heyman
President, Chief Executive Officer, Co-Founder, Director
David Mack
Chief Financial Officer, Chief Operating Officer
Winston Kung
Chief Medical Officer
Leila Alland
Chief Regulatory and Quality Assurance Officer
Deepika Jalota

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$542.9M
Revenue (TTM)
$0.00
Shares Outstanding
45.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.52
Book Value
$6.79
P/E Ratio
-8.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.